Alterity Therapeutics Soared Over 36% in Premarket Trading_老虎社区_美港股上老虎

Alterity Therapeutics Soared Over 36% in Premarket Trading

Tiger Newspress2022-01-06

Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.

The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

6a470c
·2022-01-06
Ok
回复
2
举报
收起
- 6a470c:
  ..
  2022-01-06
  回复
  举报
KW1
·2022-01-06
Ok
回复
3
举报
投资不是一两天
·2022-01-06
like
回复
3
举报
收起
- LLQ_:
  ok
  2022-01-06
  回复
  举报
karen521818
·2022-01-06
like
回复
3
举报
收起
- KW1:
  ok
  2022-01-06
  回复
  举报
- 投资不是一两天:
  oo
  2022-01-06
  回复
  举报
miaoyin88
·2022-01-06
like
回复
4
举报
收起
- karen521818:
  ok
  2022-01-06
  回复
  举报
- miaoyin88:
  ok
  2022-01-06
  回复
  举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohunote.com/m/news/1116653019?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-01-06 17:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116653019","market":"us","top_or_hot":-1,"title":"Alterity Therapeutics Soared Over 36% in Premarket Trading","media":"Tiger Newspress","content":"<html><head></head><body><p>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Soared Over 36% in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Soared Over 36% in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-06 17:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATHE","symbol_name":"Alterity Therapeutics Limited","start_time":0,"source_url":"","article_id":"1116653019","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116653019","pubTimestamp":1641460234,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATHE":"Alterity Therapeutics Limited"},"translate_title":"变态疗法在盘前交易中飙升超过36%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATHE":0.9},"content_text":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[{"id":695235624,"gmtCreate":1641466480736,"gmtModify":1641466480890,"author":{"id":"3583887401916273","authorId":"3583887401916273","name":"6a470c","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[],"authorIdStr":"3583887401916273","idStr":"3583887401916273"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/695235624","repostId":1116653019,"repostType":4,"repost":{"id":"1116653019","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641460234,"share":"https://www.laohunote.com/m/news/1116653019?lang=zh_CN&edition=full","pubTime":"2022-01-06 17:10","market":"us","language":"en","title":"Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116653019","media":"Tiger Newspress","summary":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a","content":"<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-06 17:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATHE":"Alterity Therapeutics Limited"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116653019","content_text":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.","news_type":1,"symbols_score_info":{"ATHE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7159254,"gmtCreate":1641466486541,"gmtModify":1641466486576,"authorId":3583887401916273,"author":{"id":3583887401916273,"idStr":"3583887401916273","authorId":3583887401916273,"name":"6a470c","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":695235624,"type":1,"supId":0,"prevId":0,"content":"..","text":"..","html":".."}],"langContent":"CN"},{"id":695230686,"gmtCreate":1641464544268,"gmtModify":1641464599547,"author":{"id":"3563714281601583","authorId":"3563714281601583","name":"KW1","avatar":"https://static.tigerbbs.com/094e3f8fd8b3de3da976515926ed1403","vip":1,"crmLevel":12,"crmLevelSwitch":0,"wearingBadges":[],"authorIdStr":"3563714281601583","idStr":"3563714281601583"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695230686","repostId":1116653019,"repostType":4,"repost":{"id":"1116653019","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641460234,"share":"https://www.laohunote.com/m/news/1116653019?lang=zh_CN&edition=full","pubTime":"2022-01-06 17:10","market":"us","language":"en","title":"Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116653019","media":"Tiger Newspress","summary":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a","content":"<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-06 17:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATHE":"Alterity Therapeutics Limited"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116653019","content_text":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.","news_type":1,"symbols_score_info":{"ATHE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":695202612,"gmtCreate":1641460780673,"gmtModify":1641460781070,"author":{"id":"3576138559006730","authorId":"3576138559006730","name":"投资不是一两天","avatar":"https://static.tigerbbs.com/36e77b5b6d744959b49fda03e290c69b","vip":1,"crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[],"authorIdStr":"3576138559006730","idStr":"3576138559006730"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/695202612","repostId":1116653019,"repostType":4,"repost":{"id":"1116653019","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641460234,"share":"https://www.laohunote.com/m/news/1116653019?lang=zh_CN&edition=full","pubTime":"2022-01-06 17:10","market":"us","language":"en","title":"Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116653019","media":"Tiger Newspress","summary":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a","content":"<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-06 17:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATHE":"Alterity Therapeutics Limited"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116653019","content_text":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.","news_type":1,"symbols_score_info":{"ATHE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7159388,"gmtCreate":1641471494023,"gmtModify":1641471494060,"authorId":4100083893976530,"author":{"id":4100083893976530,"idStr":"4100083893976530","authorId":4100083893976530,"name":"LLQ_","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":695202612,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":695202085,"gmtCreate":1641460691380,"gmtModify":1641460691698,"author":{"id":"3586645063655275","authorId":"3586645063655275","name":"karen521818","avatar":"https://static.tigerbbs.com/7d25d8609ba5fe3b8c704da13a47225e","vip":1,"crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[],"authorIdStr":"3586645063655275","idStr":"3586645063655275"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/695202085","repostId":1116653019,"repostType":4,"repost":{"id":"1116653019","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641460234,"share":"https://www.laohunote.com/m/news/1116653019?lang=zh_CN&edition=full","pubTime":"2022-01-06 17:10","market":"us","language":"en","title":"Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116653019","media":"Tiger Newspress","summary":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a","content":"<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-06 17:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATHE":"Alterity Therapeutics Limited"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116653019","content_text":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.","news_type":1,"symbols_score_info":{"ATHE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7159201,"gmtCreate":1641464551596,"gmtModify":1641464551634,"authorId":3563714281601583,"author":{"id":3563714281601583,"idStr":"3563714281601583","authorId":3563714281601583,"name":"KW1","avatar":"https://static.tigerbbs.com/094e3f8fd8b3de3da976515926ed1403","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":695202085,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":7159060,"gmtCreate":1641460776459,"gmtModify":1641460776493,"authorId":3576138559006730,"author":{"id":3576138559006730,"idStr":"3576138559006730","authorId":3576138559006730,"name":"投资不是一两天","avatar":"https://static.tigerbbs.com/36e77b5b6d744959b49fda03e290c69b","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":695202085,"type":1,"supId":0,"prevId":0,"content":"oo","text":"oo","html":"oo"}],"langContent":"CN"},{"id":695206473,"gmtCreate":1641460647189,"gmtModify":1641460654800,"author":{"id":"3586835469057779","authorId":"3586835469057779","name":"miaoyin88","avatar":"https://static.tigerbbs.com/1ba7672f8fa9d91ff7732ad52283c90b","vip":1,"crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[],"authorIdStr":"3586835469057779","idStr":"3586835469057779"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/695206473","repostId":1116653019,"repostType":4,"repost":{"id":"1116653019","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641460234,"share":"https://www.laohunote.com/m/news/1116653019?lang=zh_CN&edition=full","pubTime":"2022-01-06 17:10","market":"us","language":"en","title":"Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116653019","media":"Tiger Newspress","summary":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a","content":"<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Soared Over 36% in Premarket Trading<blockquote>Alterity Therapeutics 在盘前交易中飙升超过 36%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-06 17:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p><blockquote><html><head></head><body>Alterity Therapeutics 在盘前交易中飙升超过 36%。Alterity Therapeutics (ASX:ATH) 获得了治疗神经退行性疾病（包括帕金森病和阿尔茨海默病）的化合物的美国专利。</body></html></blockquote></p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p><blockquote>根据周四的新闻稿，该专利涵盖了 80 多种化合物，并确保了一类新型铁伴侣的排他性，这种新型铁伴侣将重新分配与许多神经退行性疾病相关的过量铁。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATHE":"Alterity Therapeutics Limited"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116653019","content_text":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.","news_type":1,"symbols_score_info":{"ATHE":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7159056,"gmtCreate":1641460696630,"gmtModify":1641460696724,"authorId":3586645063655275,"author":{"id":3586645063655275,"idStr":"3586645063655275","authorId":3586645063655275,"name":"karen521818","avatar":"https://static.tigerbbs.com/7d25d8609ba5fe3b8c704da13a47225e","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":695206473,"type":1,"supId":7159051,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":7159051,"gmtCreate":1641460651193,"gmtModify":1641460651220,"authorId":3586835469057779,"author":{"id":3586835469057779,"idStr":"3586835469057779","authorId":3586835469057779,"name":"miaoyin88","avatar":"https://static.tigerbbs.com/1ba7672f8fa9d91ff7732ad52283c90b","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":695206473,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"}],"hasMoreComments":false,"newsSizeData":{"likeSize":5,"commentSize":5,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}